Powered by OpenAIRE graph
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Advances in Enzyme R...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Advances in Enzyme Regulation
Article
Data sources: UnpayWall
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
IRIS - Università degli Studi di Catania
Article . 2007
Full-Text: https://www.iris.unict.it/bitstream/20.500.11769/54655/1/Targeting%20the%20RAF_MEK_ERK%2c%20PI3K_AKT%20and%20P53%20pathways%20in%20hematopoietic%20drug%20resistance.pdf
Data sources: IRIS - Università degli Studi di Catania
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
Advances in Enzyme Regulation
Article . 2007 . Peer-reviewed
License: Elsevier TDM
Data sources: Crossref
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
Archivio istituzionale della ricerca - Alma Mater Studiorum Università di Bologna
Part of book or chapter of book . 2007
Data sources: Archivio istituzionale della ricerca - Alma Mater Studiorum Università di Bologna
Advances in Enzyme Regulation
Article . 2007
Data sources: Europe PubMed Central
https://dx.doi.org/10.1016/j.a...
Article
Data sources: Microsoft Academic Graph
 View all 4 versions

Targeting the RAF/MEK/ERK, PI3K/AKT and P53 pathways in hematopoietic drug resistance

descriptionPublicationkeyboard_double_arrow_right Article , Part of book or chapter of book 01 Jan 2007 English Publisher:Elsevier BVJournal:Advances in Enzyme Regulation, volume 47, pages 64-103 (issn: 0065-2571, Copyright policy )
Authors: McCubrey J. A.; Steelman L. S.; Franklin R. A.; Abrams S. L.; Chappell W. H.; Wong E. W.; Lehmann B. D.; +6 Authors

doi: 10.1016/j.advenzreg.2006.12.013

pmid: 17382374

pmc: PMC2696319

handle: 11585/46797 , 20.500.11769/54655 , 10342/3081

Targeting the RAF/MEK/ERK, PI3K/AKT and P53 pathways in hematopoietic drug resistance

Abstract

hematopoietic drug resistance, acute myeloid leukemia, RAF/MEK/ERK pathway, PI3K/AKT pathway, P53 pathway

Related Organizations
Keywords

Mitogen-Activated Protein Kinase Kinases, Acute myeloid leukemia, RAF/MEK/ERK pathway, Hematopoietic drug resistance, Antineoplastic Agents, PI3K/AKT pathway, Mice, Phosphatidylinositol 3-Kinases, Drug Delivery Systems, Drug Resistance, Neoplasm, Cell Line, Tumor, Hematologic Neoplasms, Animals, raf Kinases, p53 pathway, Tumor Suppressor Protein p53, Extracellular Signal-Regulated MAP Kinases, Proto-Oncogene Proteins c-akt, Phosphoinositide-3 Kinase Inhibitors, Signal Transduction

  • BIP!
    Impact byBIP!
    citations
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 75
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    		 Top 10%
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 Top 10%
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    		 Top 10%
Powered by OpenAIRE graph
citations
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
75
Top 10%
Top 10%
Top 10%
bronze
Related to Research communities
Knowmad Institut
Cancer Research